[Surgery for advanced stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa]
- PMID: 30792175
- DOI: 10.1016/j.gofs.2019.01.003
[Surgery for advanced stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa]
Abstract
Debulking surgery is the key step of advanced stage ovarian cancer treatment with chemotherapy. The quality of surgical resection is the main prognosis factor, thus a complete resection must be achieved (grade A) in an expert center (grade B). Surgery for stage IV is possible and has a benefit in case of complete peritoneal resection (LoE3). Pelvic and aortic lymphadenectomies are recommended in case of clinical or radiological suspicious lymph nodes (grade B). In absence of clinical or radiological suspicious lymph nodes and in case of complete peritoneal resection during initial debulking surgery, lymphadenectomy can be omitted because it won't change nor medical treatment nor overall survival (grade B). Neoadjuvant chemotherapy can be proposed in case of: impossibility to perform initial complete surgical resection (grade B) ; alteration of general state or co-morbidities or elderly patient (in order to decrease morbidity and increase quality of life) (grade B); stage IV with multiple intra-hepatic or pulmonary metastasis or important ascites with miliary (grade B). In case of stage III or IV ovarian cancer diagnosed on a biopsy during prior laparotomy, a neoadjuvant chemotherapy and interval debulking surgery should be preferred (gradeC). In case of palliative surgery or peroperative impossibility to perform a complete resection, no data regarding the type of surgery to perform influencing survival or quality of life is available. Peritoneal carcinosis description before resection and residual disease at the end of the surgery should be reported (size, location and reason of non-extirpability) (grade B). A score of peritoneal carcinosis such as Peritoneal Carcinosis Index (PCI) should be used in order to objectively evaluate the tumoral burden (gradeC). A standardized operative report is recommended (gradeC).
Keywords: Advanced ovarian cancer; Cancer avancé de l’ovaire; Chiomiothérapie néoadjuvante; Chirurgie de cytoréduction; Debulking surgery; Lymphadenectomy; Lymphadénectomie; Neoadjuvant chemotherapy; Reliquat tumoral; Residual disease.
Copyright © 2019. Published by Elsevier Masson SAS.
Similar articles
-
[Surgery in early-stage ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].Gynecol Obstet Fertil Senol. 2019 Feb;47(2):168-179. doi: 10.1016/j.gofs.2018.12.007. Epub 2019 Jan 25. Gynecol Obstet Fertil Senol. 2019. PMID: 30686727 Review. French.
-
[Epithelial ovarian cancer and elderly patients. Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].Gynecol Obstet Fertil Senol. 2019 Feb;47(2):238-249. doi: 10.1016/j.gofs.2018.12.008. Epub 2019 Feb 1. Gynecol Obstet Fertil Senol. 2019. PMID: 30712964 Review. French.
-
[Part I drafted from the short text of the French Guidelines entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa. (Diagnosis management, surgery, perioperative care, and pathological analysis)].Gynecol Obstet Fertil Senol. 2019 Feb;47(2):100-110. doi: 10.1016/j.gofs.2018.12.010. Epub 2019 Jan 24. Gynecol Obstet Fertil Senol. 2019. PMID: 30686724 French.
-
[Management of epithelial ovarian cancer. Short text drafted from the French joint recommendations of FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY and endorsed by INCa].Bull Cancer. 2019 Apr;106(4):354-370. doi: 10.1016/j.bulcan.2019.01.014. Epub 2019 Mar 6. Bull Cancer. 2019. PMID: 30850152 Review. French.
-
[Diagnostic and prognostic value of tumor markers, scores (clinical and biological) algorithms, in front of an ovarian mass suspected of an epithelial ovarian cancer: Article drafted from the French Guidelines in oncology entitled "Initial management of patients with epithelial ovarian cancer" developed by FRANCOGYN, CNGOF, SFOG, GINECO-ARCAGY under the aegis of CNGOF and endorsed by INCa].Gynecol Obstet Fertil Senol. 2019 Feb;47(2):134-154. doi: 10.1016/j.gofs.2018.12.013. Epub 2019 Feb 5. Gynecol Obstet Fertil Senol. 2019. PMID: 30733191 Review. French.
Cited by
-
Splenectomy during cytoreductive surgery in advanced epithelial ovarian cancer can be predicted.Eur J Obstet Gynecol Reprod Biol X. 2025 May 9;26:100395. doi: 10.1016/j.eurox.2025.100395. eCollection 2025 Jun. Eur J Obstet Gynecol Reprod Biol X. 2025. PMID: 40486981 Free PMC article. Review.
-
Prediction for 2-year mortality of metastatic ovarian cancer patients based on surveillance, epidemiology, and end results database.Front Surg. 2022 Sep 15;9:974536. doi: 10.3389/fsurg.2022.974536. eCollection 2022. Front Surg. 2022. PMID: 36338661 Free PMC article.
-
Assessment of Lymph Node Involvement with PET-CT in Advanced Epithelial Ovarian Cancer. A FRANCOGYN Group Study.J Clin Med. 2021 Feb 5;10(4):602. doi: 10.3390/jcm10040602. J Clin Med. 2021. PMID: 33562725 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous